Clinical trial

ImmunoBreast - A Phase Ib Study

NCT04609215

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2020-04-21

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2020-04-21Date precision: day

Registry last updated2022-04-20

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Triple Negative Breast Cancerunresolved

Breast Cancerunresolved

Metastatic Breast Cancerunresolved

Interventions

ALECSATOTHER

Sponsors & collaborators

Henrik Ditzellead sponsor

CytoVac A/Scollaborator

National Board of Health, Denmarkcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04609215 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.